Yong Tian

Biography

1997-2002　　 Ph.D., Genetics Department of Medical Genetics Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China. 1992-1997　　 M.D., Medicine Department of Clinical Medicine, School of Medicine Beijing Medical University, Beijing, China RESEARCH EXPERIENCE 2009-Present　 Professor, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China Research direction: Establishing animal research center in IBP, including transgene and gene targeting core facility in IBP. 2002-2008　 Postdoctoral Research Associate, St. Jude Children’s Research Hospital, Memphis, TN, USA Research direction: Studying mouse models of human genetic diseases. 2000-2001　 Ph.D., co-supervised by Department of Clinical Genetics, Erasmus University, Rotterdam, the Netherlands 1997-2002　 Ph.D., supervised by Department of Medical Genetics, Peking Union Medical College& Chinese Academy of Medical Sciences, Beijing, China 1997-2002　　 Ph.D., Genetics Department of Medical Genetics Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China. 1992-1997　　 M.D., Medicine Department of Clinical Medicine, School of Medicine Beijing Medical University, Beijing, China RESEARCH EXPERIENCE 2009-Present　 Professor, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China Research direction: Establishing animal research center in IBP, including transgene and gene targeting core facility in IBP. 2002-2008　 Postdoctoral Research Associate, St. Jude Children’s Research Hospital, Memphis, TN, USA Research direction: Studying mouse models of human genetic diseases. 2000-2001　 Ph.D., co-supervised by Department of Clinical Genetics, Erasmus University, Rotterdam, the Netherlands 1997-2002　 Ph.D., supervised by Department of Medical Genetics, Peking Union Medical College& Chinese Academy of Medical Sciences, Beijing, China

Research Interest

1、Modeling human disease with human disease specific iPS and ES cell differentiation and its functional assay using genome editing technique (CRISPR/Cas9). 2、Generation and characterization of transgenic and knockout mouse model for human disease using CRISPR/Cas9 technique.